Liquid Biopsy Market Analysis: Size, Growth, and Regional Insights
The global liquid biopsy market is rapidly transforming the landscape of cancer diagnostics. Valued at USD 11.91 billion in 2024 , the market is projected to grow at a CAGR of 11.9% , reaching USD 36.59 billion by 2034 . Liquid biopsy allows clinicians to detect cancer biomarkers and genetic mutations from blood or other bodily fluids, offering a safer and more efficient alternative to conventional tissue biopsies. Why Liquid Biopsy Matters Cancer remains a leading cause of death worldwide, with early detection being critical for improving survival rates. Traditional tissue biopsies are invasive, often uncomfortable, and may not capture the complete genetic heterogeneity of tumors. Liquid biopsy addresses these limitations, offering a minimally invasive, real-time view of tumor genetics. It enables early detection, therapy selection, monitoring of minimal residual disease, and evaluation of treatment resistance. Patients and clinicians inc...